A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients

Journal of the American Society of Nephrology

Volumn 10, Issue 2, 1999, Pages 294-299

  Kimura, Hideki ^a,d   Gejyo, Fumitake ^a   Yamaguchi, Tomoko ^a   Suzuki, Satoru ^a   Imura, Toshio ^a   Miyazaki, Ryoichi ^b   Arakawa, Masaaki ^c  

^a University of Fukui   (Japan)

^b Fujita Memorial Hospital   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032934077     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Held PJ, Port FK, Webb RL, Wolfe RA, Bloembergen WE. Turenne MN, Holzman E, Ojo AO, Young EW, Mauger EA: Exceipts from United States Renal Data System 1995 Annual Data Report. Am J Kidney Dis 26: S1-S186, 1995
2. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accerelated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
3. Rostand SG, Brunzell JD, Cannon RO III, Victor RG: Cardiovascular complications in renal failure. J Am Soc Nephrol 2: 1053-1062, 1991
4. Hahn R, Odette K, Mondorf H, Finke K, Sieberth HG: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48: 279-288, 1983
5. Miller GJ, Miller NE: Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1: 16-19, 1975
6. Gordon JD, Rifkind BM: High-density lipoprotein cholesterol: The clinical implications of recent studies. N Engl J Med 321: 1311-1316, 1989
7. Murai A, Tanaka T, Miyahara T, Kameyama M: Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 12: 167-172, 1981
8. Goldberg AP, Harter HR, Patsch W, Schechtman KB, Province M, Weets C, Kuisk I, McCrate MM. Schonfeld G: Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis: A possible mechanism for accelerated atherosclerosis in white men. N Engl J Med 308: 1245-1252, 1983
9. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Mori H: Impaired metabolism of high-density lipoprotein in uremic patients. Kidney Int 41: 1653-1661, 1992
10. Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Kronenberg F: Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein (a) predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 8: 1889-1898, 1997
11. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228, 1995
12. Paszty C, Maeda N, Verstuyft J, Rubin EM: Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 94: 899-903, 1994
13. Mendez AJ, Perez GO, Hsia SL: Defect in cholesteryl ester transport in serum of patients with uremia receiving maintenance hemodialysis: Increased inhibitor activity for cholesteryl ester transfer. J Lab Clin Med 111: 677-683, 1988
14. Inazu A, Jang X-C, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall AR: Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94: 1872-1882, 1994
15. Sakai N, Yamashita S, Hirano K, Menju M, Arai T, Kobayashi K, Ishigami M, Yoshida Y, Hoshino T, Nakajima N, Kameda-Takemura K, Mastuzawa Y: Frequency of exon 15 missense mutation(442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis 114: 139-145, 1995
16. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 34: 1255-1274, 1993
17. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97: 2917-2923, 1996
18. Katterman R, Joworek D, Möller G: Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 22: 245-251, 1984
19. Parthasarathy S, Barnnet J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochem Biophys Acta 1044: 275-283, 1990
20. William KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15: 551-561, 1995
21. Sentí M, Romero R, Pedro-Botet J, Pelegrí A, Xavier N, Rubiés-Prat J: Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41: 1394-1399, 1992
22. Joven J, Villela E, Ahmad S: Lipoprotein heterogeneity in endstage renal disease. Kidney Int 43: 410-418, 1993
23. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29: 469-479, 1988
24. Dubois C, Armand M, Azais-Braesco V, Portugal H, Pauli AM, Bernard P-M, Latgé C, Lafont H, Borel P, Lairon D: Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipemic adults. Am J Clin Nutr 60: 374-382, 1994
25. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR: Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 96: 2071-2074, 1995